Status | Study |
Completed |
Study Name: Diet and Hereditary Haemorrhagic Telangiectasia Condition: Hereditary Haemorrhagic Telangiectasia (HHT) Date: 2012-09-20 Interventions: Other: Questionnaire on dietary history Ot |
Completed |
Study Name: Frequency of Common Medical Conditions in People With and Without HHT Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Date: 2012-04-30 Interventions: Other: Questionnaire To capture large sufficiently large numbers of individuals for appropriate statisti |
Completed |
Study Name: Hereditary Haemorrhagic Telangiectasia Flight Safety Study Condition: Hereditary Haemorrhagic Telangiectasia Date: 2012-04-30 Interventions: Other: Aeroplane flight in the past- no active intervention for study |
Active, not recruiting |
Study Name: Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia Condition: Hereditary Hemorrhagic Telangiectasia Epistaxis Date: 2011-11-28 Interventions: Drug: Thalidomide Eligible patients will receive thalidomi |
Withdrawn |
Study Name: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Nosebleeds Date: 2011-07-29 Interventions: Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist |
Completed |
Study Name: Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Date: 2011-07-19 Interventions: Drug: Submucosal Bevacizumab 200 mg Bevacizumab, injected submucosally- 100 mg per nostril |
Completed |
Study Name: Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Date: 2011-07-18 Interventions: Drug: Bevacizumab The bevacizumab will then be sprayed by the treating physician in the clinic, under di |
Completed |
Study Name: Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Condition: Epistaxis Hereditary Hemorrhagic Telangiectasia Date: 2011-07-01 Interventions: Drug: Sodium tetradecyl sulfate (sotradecol) 3% Sodium tetradecyl sulfate (STS) is mixed with air at a r |
Recruiting |
Study Name: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Condition: Hereditary Hemorrhagic Telangiectasia Date: 2010-07-07 |
Completed |
Study Name: Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Condition: Hereditary Hemorrhagic Telangiectasia Date: 2009-12-11 Interventions: Drug: Tranexamic acid first, than placebo |